WC
ASMB icon

Woodstock Corp’s Assembly Biosciences ASMB Stock Holding History

Woodstock Corp’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-281
Closed -$64K – 176
2013
Q4 		$64K Hold
281
– – 0.01% 167
2013
Q3 		$49K Hold
281
– – 0.01% 165
2013
Q2 		$41K Buy
+281
New +$44K 0.01% 164

Other funds holding ASMB

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Woodstock Corp's ASMB Position: Q1 2014 in Review

Woodstock Corp sold out of Assembly Biosciences (ASMB) in Q1 2014, closing a stake of 281 shares — an estimated $64K sold.

Woodstock Corp first reported a position in ASMB in Q2 2013 and held it in 3 quarters. The position peaked at $64K in Q4 2013. 28 funds tracked by Wall St. Rank hold ASMB as of Q1 2014.

  • Woodstock Corp reported no remaining Assembly Biosciences position as of Q1 2014 after selling out during the quarter.
  • Woodstock Corp sold 281 Assembly Biosciences shares in Q1 2014, an estimated $64K.
  • Woodstock Corp first reported a position in Assembly Biosciences in Q2 2013 and held it in 3 quarters.
  • Woodstock Corp's Assembly Biosciences position peaked at $64K in Q4 2013.
  • 28 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2014.

Based on Woodstock Corp's 13F filing for Q1 2014, filed 7 Apr 2014.